Copyright
©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 114452
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114452
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114452
Table 1 Demographics and clinical characteristics, n (%)
| NPD (n = 117) | PD (n = 83) | Total (n = 200) | P value | ||
| Age | mean ± SD | 66.11 ± 14.64 | 58.04 ± 15.72 | 62.76 ± 15.58 | < 0.0011 |
| Median (interquartile range) | 69 (59, 76) | 62 (45, 68) | 66 (53.50, 74) | ||
| Race | White, non-Hispanic | 97 (83) | 68 (82) | 165 (83) | 0.1192 |
| Black/African American | 0 (0) | 2 (2) | 2 (1) | ||
| Hispanic | 7 (6) | 6 (7) | 13 (7) | ||
| Asian | 8 (7) | 1 (1) | 9 (5) | ||
| More than one | 0 (0) | 1 (1) | 1 (1) | ||
| Other | 4 (3) | 5 (6) | 9 (5) | ||
| Body mass index | mean ± SD | 24.89 ± 5.62 | 24.98 ± 6.37 | 24.93 ± 5.93 | 0.8141 |
| Median (interquartile range) | 23.97 (21.17, 27.50) | 23.45 (20.45, 28.29) | 23.79 (20.72, 27.76) | ||
| Past history | Diabetes | 9 (8) | 5 (6) | 14 (7) | 0.7822 |
| Cardiopulmonary morbidity | 57 (49) | 42 (51) | 99 (50) | 0.8862 | |
| Chronic steroid use | 6 (5) | 7 (8) | 13 (7) | 0.3922 | |
| Chronic cough | 4 (3) | 5 (6) | 9 (5) | 0.4942 | |
| Pelvic radiation | 3 (3) | 2 (2) | 5 (3) | 1.0002 | |
| Eating disorder | 2 (2) | 10 (12) | 12 (6) | 0.0042 | |
| Sexual trauma | 11 (9) | 15 (18) | 26 (13) | 0.0902 | |
| Chronic narcotic use | 14 (12) | 17 (20) | 31 (16) | 0.1152 | |
| Chronic constipation | 42 (36) | 43 (52) | 85 (43) | 0.0302 | |
| Chronic diarrhea | 17 (15) | 22 (27) | 39 (20) | 0.0472 | |
| History of hysterectomy | 52 (44) | 27 (33) | 79 (40) | 0.1072 | |
| Nulliparity | 26 (22) | 26 (31) | 52 (26) | 0.1902 | |
| Prior pelvic floor surgery | Cystocele | 7 (6) | 2 (2) | 9 (5) | 0.3102 |
| Rectocele | 10 (9) | 9 (11) | 19 (10) | 0.6302 | |
| Vaginal apical suspension | 3 (3) | 1 (1) | 4 (2) | 0.6432 | |
| Sacrocolpopexy | 2 (2) | 2 (2) | 4 (2) | 1.0002 | |
| Urinary incontinence procedure | 5 (4) | 6 (7) | 11 (6) | 0.5312 | |
| Sphincteroplasty | 1 (1) | 0 (0) | 1 (1) | 1.0002 |
Table 2 Primary bothersome symptoms, n (%)
| Primary bothersome symptoms | NPD (n = 117) | PD (n = 83) | Total (n = 200) | P value1 |
| Mucus discharge | 33 (28) | 23 (28) | 56 (28) | 1.0 |
| Fecal incontinence | 60 (51) | 40 (48) | 100 (50) | 0.78 |
| Obstructed defecation syndrome | 13 (11) | 14 (17) | 27 (14) | 0.3 |
| Pain | 39 (33) | 29 (35) | 68 (34) | 0.9 |
| Discomfort | 68 (34) | 22 (27) | 48 (24) | 0.5 |
| Bleeding | 14 (12) | 17 (20) | 31 (16) | 0.1 |
| Minimal symptoms | 7 (6) | 4 (5) | 11 (6) | 1.0 |
Table 3 Clinical characteristics of rectal prolapse, n (%)
| NPD (n = 117) | PD (n = 38) | Total (n = 200) | P value1 | ||
| Duration | 0-6 months | 22 (19) | 9 (11) | 31 (16) | 0.2 |
| 6 months to 1 years | 23 (20) | 10 (12) | 33 (17) | ||
| 1-2 years | 24 (21) | 24 (29) | 48 (24) | ||
| 3-5 years | 19 (16) | 19 (23) | 38 (19) | ||
| Description of the prolapse | Prolapse with defecation | 81 (69) | 64 (77) | 145 (73) | 0.3 |
| Prolapse with exercise | 14 (12) | 16 (19) | 30 (15) | 0.2 | |
| Prolapse with walking | 30 (26) | 16 (19) | 46 (23) | 0.3 | |
| Prolapse all the time | 20 (17) | 14 (17) | 34 (17) | 1.0 | |
| Type of prolapse | Full thickness | 98 (84) | 73 (88) | 171 (86) | 0.5 |
| Internal prolapse | 19 (16) | 10 (12) | 29 (15) | ||
| Co-existing urinary incontinence | Yes | 57 (49) | 39 (47) | 96 (48) | 0.8 |
| Unknown | 2 (2) | 3 (4) | 5 (3) | ||
| Recurrent rectal prolapse | 30 (26) | 20 (24) | 50 (25) | 0.9 |
Table 4 Pelvic Floor Distress Inventory Questionnaire
| NPD (n = 117) | PD (n = 83) | P value1 | Difference in medians (95%CI)2 | ||
| PFDI-20 | Median (IQR) | 101.04 (67.71, 150.00) | 137.50 (77.08, 180.21) | 0.035 | 38.24 (3.71-53.96) |
| Pelvic Organ Prolapse Distress Inventory | Median (IQR) | 25.00 (16.67, 41.67) | 33.33 (16.67, 50.00) | 0.078 | 4.64 (-4.26 to 15.83) |
| Colorectal-Anal Distress Inventory | Median (IQR) | 50.00 (34.38, 68.75) | 62.50 (43.75, 81.25) | 0.007 | 11.33 (-1.43 to 22.51) |
| Urinary Distress Inventory | Median (IQR) | 25.00 (8.33, 45.00) | 29.17 (16.67, 62.50) | 0.12 | 4.39 (-3.71 to 18.88) |
Table 5 Pelvic Floor Impact Questionnaire
| NPD (n = 113) | PD (n = 80) | P value1 | Difference in medians (95%CI)2 | ||
| PFIQ | Median (IQR) | 80.95 (38.10, 142.86) | 100.00 (59.52, 171.43) | 0.024 | 16.19 (-10.47 to 51.29) |
| Urinary Impact Questionnaire | Median (IQR) | 11.11 (0.00, 38.10) | 23.81 (0.00, 52.38) | 0.068 | 14.12 (1.52-23.63) |
| Colorectal-Anal Impact Questionnaire | Median (IQR) | 47.62 (28.57, 80.95) | 66.67 (40.48, 85.71) | 0.027 | 14.29 (2.93-29.69) |
| Pelvic Organ Prolapse Impact Questionnaire | Median (IQR) | 0.00 (0.00, 33.33) | 4.76 (0.00, 50.00) | 0.194 | 4.76 (-1.49 to 19.82) |
Table 6 Cleveland Clinic Fecal Incontinence and Obstructed Defecation Syndrome scores
- Citation: Akeel N, Rajasingh CM, Earley M, Au Hoy S, Neshatian L, Enemchukwu E, Mishra K, Gurland B. Perception of rectal prolapse symptoms in patients with psychiatric disorders. World J Gastrointest Surg 2026; 18(1): 114452
- URL: https://www.wjgnet.com/1948-9366/full/v18/i1/114452.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i1.114452
